JOHNSON & JOHNSON (JNJ)
Data as of , from SEC Form 4 filings.
See up to 3 months of JNJ. The 7-day demo opens the 1M and 3M ranges and puts JNJ on your watchlist.
Start 7-day demoLatest JNJ insider trades
About JOHNSON & JOHNSON (JNJ)
JOHNSON & JOHNSON files with the SEC under CIK 0000200406 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
JNJ Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 10 | 259,340 | $67.78M |
| Grant or award | 3 | 429.77 | |
| Option exercise | 14 | 408,572 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
JNJ insider transactions (Form 4)
5574 Form 4 filings on record, the earliest from Oct 15, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Daniel E. Pinto - Director | Grant or award | Deferred Share Units | 113.1 | $276.31 | $31K | |
| Eugene A. Woods - Director | Grant or award | Deferred Share Units | 135.72 | $276.31 | $37K | |
 Marillyn A. Hewson - Director | Grant or award | Deferred Share Units | 180.96 | $276.31 | $50K | |
| Timothy Schmid - Officer | Option exercise | Common Stock | 22,527 | $151.41 | $3.41M | |
| Timothy Schmid - Officer | Open-market sale | Common Stock | 22,527 | $274.74 | $6.19M | |
| Timothy Schmid - Officer | Option exercise | Common Stock | 11,070 | $131.94 | $1.46M | |
| Timothy Schmid - Officer | Open-market sale | Common Stock | 11,070 | $274.74 | $3.04M | |
| Timothy Schmid - Officer | Option exercise | Employee Stock Options (Right to Buy) | 11,070 | $0.00 | - | |
| Timothy Schmid - Officer | Option exercise | Employee Stock Options (Right to Buy) | 22,527 | $0.00 | - | |
 Jennifer L. Taubert - Officer | Option exercise | Common Stock | 15,000 | $115.67 | $1.74M | |
| Jennifer L. Taubert - Officer | Open-market sale | Common Stock | 15,000 | $263.36 footnote F1 | $3.95M | |
| Jennifer L. Taubert - Officer | Option exercise | Employee Stock Options (Right to Buy) | 15,000 | $0.00 | - | |
| ||||||
 Joaquin Duato - Officer | Option exercise | Common Stock | 123,291 | $115.67 | $14.26M | |
| Joaquin Duato - Officer | Open-market sale | Common Stock | 20,976 | $262.00 | $5.50M | |
| Joaquin Duato - Officer | Open-market sale | Common Stock | 102,315 | $261.00 | $26.70M | |
| Joaquin Duato - Officer | Option exercise | Employee Stock Options (Right to Buy) | 123,291 | $0.00 | - | |
| Joaquin Duato - Officer | Open-market sale | Common Stock | 41,957 | $258.06 footnote F1 | $10.83M | |
| Joaquin Duato - Officer | Open-market sale | Common Stock | 6,523 | $258.74 footnote F2 | $1.69M | |
| ||||||
| Elizabeth Forminard - Officer | Open-market sale | Common Stock | 6,574 | $255.93 | $1.68M | |
| Elizabeth Forminard - Officer | Open-market sale | Common Stock | 9,344 | $257.76 | $2.41M | |
| Elizabeth Forminard - Officer | Option exercise | Common Stock | 9,344 | $131.94 | $1.23M | |
| Elizabeth Forminard - Officer | Option exercise | Employee Stock Options (Right to Buy) | 9,344 | $0.00 | - | |
| Vanessa Broadhurst - Officer | Option exercise | Common Stock | 11,129 | $129.51 | $1.44M | |
| Vanessa Broadhurst - Officer | Option exercise | Common Stock | 11,925 | $131.94 | $1.57M | |
| Vanessa Broadhurst - Officer | Open-market sale | Common Stock | 23,054 | $251.27 footnote F1 | $5.79M | |
| Vanessa Broadhurst - Officer | Option exercise | Employee Stock Options (Right to Buy) | 11,129 | $0.00 | - | |
| Vanessa Broadhurst - Officer | Option exercise | Employee Stock Options (Right to Buy) | 11,925 | $0.00 | - | |
| ||||||
| Kathryn E. Wengel - Officer | Open-market sale | Common Stock | 10,000 | $241.15 footnote F1 | $2.41M | |
| Kathryn E. Wengel - Officer | Option exercise | Employee Stock Options (Right to Buy) | 10,000 | $0.00 | - | |
| Kathryn E. Wengel - Officer | Option exercise | Common Stock | 10,000 | $115.67 | $1.16M | |
| ||||||
| Eugene A. Woods - Director | Grant or award | Deferred Share Units | 161.09 | $232.79 | $37K | |
| Daniel E. Pinto - Director | Grant or award | Deferred Share Units | 134.24 | $232.79 | $31K | |
| Marillyn A. Hewson - Director | Grant or award | Deferred Share Units | 214.79 | $232.79 | $50K | |
 John C. Reed - Officer | Option exercise | Common Stock | 25,255 footnote F1 | $0.00 | - | |
| John C. Reed - Officer | Tax withholding / forfeiture | Common Stock | 11,002 footnote F2 | $229.85 | $2.53M | |
| John C. Reed - Officer | Option exercise | Restricted Share Units | 25,255 | $0.00 | - | |
| ||||||
| Eugene A. Woods - Director | Grant or award | Deferred Share Units | 975 | $0.00 | - | |
| Nadja West - Director | Grant or award | Deferred Share Units | 975 | $0.00 | - | |
 Mark A. Weinberger - Director | Grant or award | Deferred Share Units | 975 | $0.00 | - | |
| Daniel E. Pinto - Director | Grant or award | Deferred Share Units | 1,712 | $0.00 | - | |
 John G. Morikis - Director | Grant or award | Deferred Share Units | 1,540 | $0.00 | - | |
 Mark B. McClellan - Director | Grant or award | Deferred Share Units | 975 | $0.00 | - | |
 Hubert Joly - Director | Grant or award | Deferred Share Units | 975 | $0.00 | - | |
 Paula A. Johnson - Director | Grant or award | Deferred Share Units | 975 | $0.00 | - | |
| Marillyn A. Hewson - Director | Grant or award | Deferred Share Units | 975 | $0.00 | - | |
| Jennifer A. Doudna - Director | Grant or award | Deferred Share Units | 975 | $0.00 | - | |
 Mary C. Beckerle - Director | Grant or award | Deferred Share Units | 975 | $0.00 | - | |
| Marillyn A. Hewson - Director | Grant or award | Deferred Share Units | 206.49 | $242.14 | $50K | |
| Marillyn A. Hewson - Director | Grant or award | Deferred Share Units | 75.26 | $166.10 | $13K | |
| Daniel E. Pinto - Director | Grant or award | Deferred Share Units | 129.06 | $242.14 | $31K | |
| Eugene A. Woods - Director | Grant or award | Deferred Share Units | 154.87 | $242.14 | $37K | |
| Robert J. Decker - Officer | Option exercise | Common Stock | 4,075 | $115.67 | $471K | |
| Robert J. Decker - Officer | Open-market sale | Common Stock | 4,075 | $247.87 | $1.01M | |
| Robert J. Decker - Officer | Option exercise | Employee Stock Options (Right to Buy) | 4,075 | $0.00 | - | |
| Timothy Schmid - Officer | Open-market sale | Common Stock | 1,322 | $245.66 | $325K | |
Item 2.02, 9.01
Item 5.02, 9.01
Item 7.01, 9.01
Item 7.01, 9.01
Recent JNJ Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Schmid Timothy | Officer | 33,597 | $9.23M | View on EDGAR | |
| Taubert Jennifer L | Officer | 15,000 | $3.95M |
Stock trades in JNJ disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Lloyd DoggettDemocrat, TX-37 | Purchase |
JNJ insider trading FAQ
What is the latest insider trade for JNJ?
JOHNSON & JOHNSON (JNJ) had 9 insider filings in the last 90 days, with the most recent on 2026-09-11. The full record for JNJ runs to 74 Form 4 filings, the earliest from 2024-10-15. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying JNJ stock?
No insider purchases of JNJ were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling JNJ stock?
10 insider sales of JNJ were filed in the last 90 days, totaling $67.78M.
Where can I see JNJ SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects JNJ Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Daniel E. Pinto view on EDGAR
- - Eugene A. Woods view on EDGAR
- - Marillyn A. Hewson view on EDGAR
- - Timothy Schmid view on EDGAR
- - Jennifer L. Taubert view on EDGAR
- - Joaquin Duato view on EDGAR
- - Joaquin Duato view on EDGAR
- - Elizabeth Forminard view on EDGAR
- - Vanessa Broadhurst view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where JNJ's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow JNJ with a 7-day demo
- JNJ on your watchlist
- Every JNJ Form 4 filing on record
- Up to 3 months of JNJ price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
